Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Sun Pharma’s fosphenytoin sodium injection
Fosphenytoin sodium injection USP, 50mg PE/mL, is therapeutically equivalent to Parke Davis’s Cerebyx, and is available in two packs: 100mg PE/ 2mL and 500mg PE/10mL single dose vials.
Fosphenytoin sodium injection USP, 50mg PE/mL, is therapeutically equivalent to Parke Davis’s Cerebyx, and is available in two packs: 100mg PE/ 2mL and 500mg PE/10mL single dose vials.
The study will comprise 306 new onset type 1 diabetes patients. Diamyd Medical is planning to file clinical trial applications in another three to four European countries and
Combined with the past FDA clearances for obtaining access, cleaning and shaping, this clearance allows Biolase users to perform the complete root canal procedure using FDA cleared procedures.
Several compounds or new chemical entities (NCEs) from this class lower glucose and improve insulin sensitivity in preclinical models of type 2 diabetes. The patent covers the first
The Trust study is a randomized, multicenter trial of patients with implantable cardioverter defibrillators using Biotronik Lumos and Lumax devices. The Trust study will evaluate the effectiveness of
The entire Phase III program comprised of almost 3000 patients in five studies, the pivotal trial being the largest ever conducted with 1443 patients treated out of 2437
A priority designation is intended for products or indications that address unmet medical needs. Under the Prescription Drug User Fee Act, the FDA’s goal is to review and
Cenix will apply its expertise in combining high throughput (HT) applications of RNA interference (RNAi) based gene silencing with high content phenotypic analyses in cultured human cells. The
In this study, mice were vaccinated with a range of doses of the company’s VLP vaccine made from an Indonesian strain of H5N1 avian influenza. During the experiment,
Max food ingredients was formed for the purpose of selling Forbes’s proprietary sterol ingredient, Reducol, and has obtained exclusive rights for Germany, Austria and Switzerland. Laura Wessman, senior